HUTCHMED (HCM) CFO reports options and share stakes in Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
HUTCHMED (China) Ltd Chief Financial Officer Cheng Chig Fung filed an initial ownership report showing existing equity holdings, not new trades. He holds several share options over American depositary shares with exercise prices of $22.0900, $27.9400, $10.7500 and $12.5100, expiring between 2030 and 2033.
The filing also lists 1,463,698 ordinary shares and 56,693 American depositary shares held directly, plus 38,567 ordinary shares held indirectly through a Long Term Incentive Plan. Each American depositary share represents 5 ordinary shares, and plan awards are scheduled to vest in 2027 subject to vesting criteria.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Cheng Chig Fung
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share option (right to buy) | -- | -- | -- |
| holding | Share option (right to buy) | -- | -- | -- |
| holding | Share option (right to buy) | -- | -- | -- |
| holding | Share option (right to buy) | -- | -- | -- |
| holding | Long Term Incentive Plan awards granted on 08/05/2024 | -- | -- | -- |
| holding | ordinary shares | -- | -- | -- |
| holding | American depositary shares | -- | -- | -- |
Holdings After Transaction:
Share option (right to buy) — 80,380 shares (Direct);
Long Term Incentive Plan awards granted on 08/05/2024 — 38,567 shares (Indirect, Held by Long Term Incentive Plan trustee);
ordinary shares — 1,463,698 shares (Direct);
American depositary shares — 56,693 shares (Direct)
Footnotes (1)
- Each American depositary share represents 5 ordinary shares. The share options granted are exercisable subject to, amongst other relevant vesting criteria, the vesting schedule of 25% on each of the first, second, third and fourth anniversaries of the date of grant of share options. The exercise price for the share option is denominated in United States dollar per American depositary share. All Long Term Incentive Plan Awards will vest in 2027, three weeks after the date of completion of the share purchase for the awards for the financial year ending December 31, 2026.
FAQ
What does HUTCHMED (HCM) CFO Cheng Chig Fung report in this Form 3?
The Form 3 reports Cheng Chig Fung’s existing equity holdings in HUTCHMED, not new trades. It lists ordinary shares, American depositary shares, and multiple share option grants with specified exercise prices, expiration dates, and related Long Term Incentive Plan awards.
What option awards over HUTCHMED (HCM) ADS does the Form 3 disclose?
The filing lists several share options over American depositary shares with exercise prices of $22.0900, $27.9400, $10.7500 and $12.5100, expiring between 2030 and 2033, giving the CFO long-dated incentives tied to ADS performance.
What Long Term Incentive Plan awards does the HUTCHMED (HCM) CFO hold?
The CFO has 38,567 ordinary shares held indirectly through a Long Term Incentive Plan. Footnotes state these awards are expected to vest in 2027, three weeks after completion of the share purchase for the financial year ending December 31, 2026.